相关实验视频

Updated: May 27, 2025

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

用自扩展金属支架进行内镜血静,作为血红病的桥梁疗法

Junyeol Kim^1,2, Jin Ho Choi¹, Tae Seung Lee¹

¹Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Jongno-gu, Korea (the Republic of).

Endoscopy international open

|February 17, 2025

概括

使用自扩展金属支架 (SEMS) 的内镜血静止是一种可行的血红病桥梁疗法,可以减少总血红病时间. 这种方法在管理这种具有挑战性的条件方面显示出有希望的结果.

科学领域:

胃肠病学胃肠病学
干预性内镜检查是干预性的内镜检查.
血管外科血管外科

背景情况:

血红细胞的管理带来了重大的临床挑战.
用自扩展金属支架 (SEMS) 进行内镜血静已经成为在内镜缩切除部位出血的潜在治疗方法.
这项研究评估了内镜血液静止作为血红病的桥梁疗法.

研究的目的:

评估内镜血液静止的有效性和可行性,作为血液病的桥梁治疗.
为了比较内镜血液静止与血管造血栓塞,用于血液病管理.

主要方法:

对26名患有血病的患者 (2008-2023) 的回顾性审查.
在内镜血液静止 (ENDO组,n=17) 和血管图片栓塞 (EMBO组,n=9) 之间的初始血液静止成功率的比较.
评估二次结果,包括延迟出血,28天死亡率,输血需求和血液静止的时间.

主要成果:

最初的血液静止成功率为ENDO的88.2%和EMBO的100% (P=0.529).
延迟出血发生在ENDO组的17.6%,而EMBO组的0.0% (P=0.529).
与EMBO组 (平均5002.8分钟) 相比,ENDO组的总血时间显著缩短 (平均281.5分钟) (P < 0.001). 支架插入深度与成功的血液静止相关 (P=0.015).

结论:

使用SEMS的内镜血静止是一种可行且有效的血红病桥梁疗法.
这种内镜方法可以显著减少血的持续时间,而不是血管学栓塞.

关键词:

关于ERC的主题胃肠道放射学胃肠道放射学胰腺胆性疾病 (ERCP/PTCD) 是一种

更多相关视频

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

相关概念视频

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...